Serum periostin levels in infants with acute RS virus bronchitis

Serum periostin levels in infants with acute RS virus bronchitis - PERSII study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012339

Enrollment

Registered

2013-11-19

Start date

2013-10-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute RS virus bronchitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: group 1:Patients who were admitted to the hospital for acute RS virus bronchitis( modified asthma predictive index(+/-)) group 2:food allergic patients (positive control) group 3:surgery scheduled patients (negative control)

Exclusion criteria

Exclusion criteria: 1.Patients with heart disease 2.Patients with bronchial asthma 3.Patients with allergic rhinitis 4.Patients with renal disease 5.Patients with bone disease 6.Patients with muscle disease 7.Patients with malignant tumor 8.Patients who received systemic administration of steroids within one month

Design outcomes

Primary

Measure	Time frame
We compare the serum periostin leves between control group and acute RS virus bronchitis group (modified asthma predictive index (+) and modified asthma predictive index (-)).	—

Secondary

Measure	Time frame
We investigate the chronological changes in periostin levels in acute RS virus bronchitis group. We investigate the relationship between serum periostin levels and disease severity by modified pulmonary index score in acute RS virus bronchitis group. We investigate the relationship between serum periostin levels and Th2-related molecules in acute RS virus bronchitis group.	—

Countries

Japan

Contacts

Public ContactKenichi Akashi

The Jikei University Daisan Hospital Pediatrics

akashi@jikei.ac.jp03-3480-1151

Outcome results